Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hila Ben-Moshe"'
Autor:
Tzofnat Bareli, Hadas Levi Ahdoot, Hila Ben Moshe, Royi Barnea, Gal Warhaftig, Iris Gispan, Rachel Maayan, Paola Rosca, Abraham Weizman, Gal Yadid
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 15 (2021)
Substance use disorders (SUDs) are associated with depression and anxiety, with the latter being one of the major factors in substance-seeking and relapse. Due to dose-dependent sedative side effects there is limited efficacy of baclofen treatment fo
Externí odkaz:
https://doaj.org/article/214d68268744427e87825d196dca7b22
Autor:
Abraham Weizman, Hadas Ahdoot, Rachel Maayan, Royi Barnea, Paola Roska, Hila Ben-Moshe, Gal Yadid, Gal Warhaftig, Tzofnat Bareli
Publikováno v:
Addiction biologyREFERENCES. 26(5)
Ras-related C3 botulinum toxin substrate 1 (Rac1), of the Rho small GTPase family, is a key regulator of actin cytoskeleton rearrangement and plays an important role in dendritic morphogenesis. Cocaine produces neuronal alterations, including structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4464b723305e3e7c958ea0d8fa2948fc
https://pubmed.ncbi.nlm.nih.gov/33508873
https://pubmed.ncbi.nlm.nih.gov/33508873
Autor:
Daniel M. Michaelson, Shiran Salomon-Zimri, Ishai Luz, Hila Ben-Moshe, Anat Boehm-Cagan, Ori Liraz
Publikováno v:
Journal of molecular neuroscience : MN. 70(1)
The ɛ4 allele of apolipoprotein E (apoE4) is the most prevalent genetic risk factor for Alzheimer’s disease. ApoE4 is also associated with poor recovery and functional outcome following traumatic brain injury. This study examined the effects of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa9d7685a6008f0e5442ec2822359a27
https://pubmed.ncbi.nlm.nih.gov/31489583
https://pubmed.ncbi.nlm.nih.gov/31489583
Autor:
Elad Lax, Efrat Sasson, Ofri Croitoru, Hila Ben-Moshe, Alexander Friedman, Lior Redlus, Yaniv Assaf, Gal Yadid, Einav Sudai, Tamar Blumenfeld-Katzir
Publikováno v:
Neuropharmacology. 75:246-254
Deep brain stimulation (DBS) is an emerging technique for effective, non-pharmacological intervention in the course of neurological and neuropsychiatric diseases. Several brain targets have been suggested as suitable for DBS treatment of drug addicti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1572d788d546366fe6fdac5cce661458
https://doi.org/10.1016/j.neuropharm.2013.06.034
https://doi.org/10.1016/j.neuropharm.2013.06.034